A noncompliant, high pressure balloon to manage undilatable coronary lesions

Yogesh Raja1, Helen C Routledge, Sagar N Doshi

  • 1Department of Interventional Cardiology, Queen Elizabeth University Hospital, Birmingham, UK.

Insights

Treating undilatable coronary lesions with calcification is challenging. The OPN NC high-pressure balloon successfully treated four cases where standard balloons failed, preventing stent underexpansion.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Biomedical Engineering

Background:

  • Undilatable coronary lesions, often caused by calcification, pose a significant challenge in percutaneous coronary intervention.
  • Stent underexpansion in calcified lesions increases risks of stent thrombosis and restenosis, highlighting the need for effective treatment strategies.

Observation:

  • The OPN NC (SIS-Medical AG) is a high-pressure balloon catheter featuring a novel twin-layer technology designed for uniform expansion.
  • This technology aims to overcome the limitations of standard noncompliant balloons in treating severely calcified coronary arteries.

Findings:

  • Four cases are presented where the OPN NC balloon was successfully used to treat calcified coronary lesions.
  • These cases involved lesions that were resistant to dilatation even after high-pressure inflation with standard noncompliant balloons.

Implications:

  • The OPN NC balloon demonstrates potential as an effective tool for managing undilatable calcified coronary lesions.
  • Successful treatment may reduce the incidence of stent underexpansion and its associated adverse clinical outcomes.

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...